⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Sonar Joins OpenAI Daybreak Cyber Partner Program to Advance Frontier Security
prnewswire.com
NVDA
NOW
GS
AZN
F
Arteriosclerosis Obliterans Market Shows Promising Growth Prospects During the Forecast Period (2026-2036) Amid Evolving Treatment Landscape | DelveInsight
prnewswire.com
LLY
REGN
LSTA
ABT
PFE
JNJ
MRK
BMY
AZN
NVS
AMGN
GILD
BIIB
Autologous Cell Therapy Market Size, Share, and Outlook - Growth Analysis and Forecast, 2026-2035 | CAR-T and Personalized Oncology Fuel 19.40% CAGR to USD 54.83 Billion
globenewswire.com
AZN
GILD
JNJ
BMY
VERI
LCTX
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
globenewswire.com
MYGN
SOPH
AZN
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
prnewswire.com
SOPH
AZN
MYGN
PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
globenewswire.com
TMO
AGNC
QGEN
EXAS
LH
DGX
BNTX
CRSP
REGN
GILD
AMGN
BMY
MRK
PFE
ABBV
LLY
AZN
SNY
NVS
BIIB
VRTX
BMRN
IDXX
CRWD
DDOG
SNOW
NVDA
AMD
INTC
MSFT
QDEL
MYGN
SENS
INM
PRPO
CODX
BFC
BSY
NCL
ABT
DHR
BDX
BIO
BRKR
CTAS
CUE
HOLX
Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 67 Billion as Targeted Therapies Drive 6.6% CAGR
globenewswire.com
PFE
MRK
JNJ
LLY
BMY
AZN
REGN
VRTX
RMD
BIIB
GILD
AMGN
ABBV
VERU
The Mark Foundation Awards $12 Million to Cross-Disciplinary Cancer Research Teams
prnewswire.com
NVS
MRK
BMY
GILD
AZN
PFE
JNJ
BIIB
REGN
MDLZ
Acute Myocardial Infarction (AMI) - Market Insights, Epidemiology, and Market Forecast Now Available; Acute Myocardial Infarction (AMI) Market Projected to Reach Approximately USD 6.00 Billion by 2036
globenewswire.com
AMGN
MRK
REGN
AZN
PFE
BMY
JNJ
VTRS
CELC
NVO
ARWR
Cell and Gene Therapy Market Size, Share, Trends, and Forecast 2026-2035 | Market to Reach USD 172.22 Billion as AI, Gene Editing, and CAR-T Drive 23.17% CAGR
globenewswire.com
AMGN
PFE
BIIB
BMY
VRTX
REGN
AZN
VERI